The role of histone lysine demethylase 2B in the pathology of canine hemangiosarcoma

1. Adjiri, A. (2016). Identifying and Targeting the Cause of Cancer is Needed to Cure Cancer. Oncology and Therapy, 4(1), 17–33. https://doi.org/10.1007/s40487-015- 0015-6

2. Aoshima, K., Fukui, Y., Gulay, K. C. M., Erdemsurakh, O., Morita, A., Kobayashi, A., & Kimura, T. (2018). Notch2 signal is required for the maintenance of canine hemangiosarcoma cancer stem cell-like cells. BMC Veterinary Research, 14(1), 301. https://doi.org/10.1186/s12917-018-1624-8

3. Arruebo, M., Vilaboa, N., Sáez-Gutierrez, B., Lambea, J., Tres, A., Valladares, M., & González-Fernández, Á. (2011). Assessment of the Evolution of Cancer Treatment Therapies. Cancers, 3(3), 3279–3330. https://doi.org/10.3390/cancers3033279

4. Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., James, J. A., Salto-Tellez, M., & Hamilton, P. W. (2017). QuPath: Open source software for digital pathology image analysis. Scientific Reports, 7(1), 16878. https://doi.org/10.1038/s41598-017-17204-5

5. Batschinski, K., Nobre, A., Vargas-Mendez, E., Tedardi, M. V., Cirillo, J., Cestari, G., Ubukata, R., & Dagli, M. L. Z. (2018). Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014). The Canadian Veterinary Journal = La Revue Veterinaire Canadienne, 59(9), 967–972.

6. Boom, V. van den, Maat, H., Geugien, M., López, A. R., Sotoca, A. M., Jaques, J., Brouwers-Vos, A. Z., Fusetti, F., Groen, R. W. J., Yuan, H., Martens, A. C. M., Stunnenberg, H. G., Vellenga, E., Martens, J. H. A., & Schuringa, J. J. (2016). Non- canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis. Cell Reports, 14(2), 332–346. https://doi.org/10.1016/j.celrep.2015.12.034

7. Brzostek-Racine, S., Gordon, C., Scoy, S. V., & Reich, N. C. (2011). The DNA Damage Response Induces IFN. The Journal of Immunology, 187(10), 5336–5345. https://doi.org/10.4049/jimmunol.1100040

8. Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P. (2009). Doxorubicin: The Good, the Bad and the Ugly Effect. Current Medicinal Chemistry, 16(25), 3267–3285. https://doi.org/10.2174/092986709788803312

9. Chen, J., Harding, S. M., Natesan, R., Tian, L., Benci, J. L., Li, W., Minn, A. J., Asangani, I. A., & Greenberg, R. A. (2020). Cell Cycle Checkpoints Cooperate to Suppress DNA- and RNA-Associated Molecular Pattern Recognition and Anti- Tumor Immune Responses. Cell Reports, 32(9), Article 9. https://doi.org/10.1016/j.celrep.2020.108080

10. Chen, L., Fu, L., Kong, X., Xu, J., Wang, Z., Ma, X., Akiyama, Y., Chen, Y., & Fang, J. (2014). Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer. British Journal of Cancer, 110(4), 1014–1026. https://doi.org/10.1038/bjc.2013.808

11. Clifford, C. A., Mackin, A. J., & Henry, C. J. (2000). Treatment of Canine Hemangiosarcoma: 2000 and Beyond. Journal of Veterinary Internal Medicine, 14(5), 479–485. https://doi.org/10.1111/j.1939-1676.2000.tb02262.x

12. Dawson, M. A., & Kouzarides, T. (2012). Cancer Epigenetics: From Mechanism to Therapy. Cell, 150(1), 12–27. https://doi.org/10.1016/j.cell.2012.06.013

13. Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013). STAR: Ultrafast universal RNA-seq aligner. Bioinformatics, 29(1), 15–21. https://doi.org/10.1093/bioinformatics/bts635

14. Edelheit, O., Hanukoglu, A., & Hanukoglu, I. (2009). Simple and efficient site- directed mutagenesis using two single-primer reactions in parallel to generate mutants for protein structure-function studies. BMC Biotechnology, 9(1), 61. https://doi.org/10.1186/1472-6750-9-61

15. Fosmire, S. P., Dickerson, E. B., Scott, A. M., Bianco, S. R., Pettengill, M. J., Meylemans, H., Padilla, M., Frazer-Abel, A. A., Akhtar, N., Getzy, D. M., Wojcieszyn, J., Breen, M., Helfand, S. C., & Modiano, J. F. (2004). Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Laboratory Investigation, 84(5), 562–572. https://doi.org/10.1038/labinvest.3700080

16. Goodman, L. S., & Wintrobe, M. M. (1946). Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin’s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. Journal of the American Medical Association, 132, 126–132. https://doi.org/10.1001/jama.1946.02870380008004

17. Guzmán, C., Bagga, M., Kaur, A., Westermarck, J., & Abankwa, D. (2014). ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays. PLOS ONE, 9(3), e92444. https://doi.org/10.1371/journal.pone.0092444

18. Han, X.-R., Zha, Z., Yuan, H.-X., Feng, X., Xia, Y.-K., Lei, Q.-Y., Guan, K.-L., & Xiong, Y. (2016). KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation. Oncogene, 35(32), 4179–4190. https://doi.org/10.1038/onc.2015.482

19. Harasawa, R., Mizusawa, H., Nozawa, K., Nakagawa, T., Asada, K., & Kato, I. (1993). Detection and tentative identification of dominant mycoplasma species in cell cultures by restriction analysis of the 16S-23S rRNA intergenic spacer regions. Research in Microbiology, 144(6), 489–493. https://doi.org/10.1016/0923-2508(93)90057-9

20. Harasawa, Ryô, Mizusawa, H., Fujii, M., Yamamoto, J., Mukai, H., Uemori, T., Asada, K., & Kato, I. (2005). Rapid detection and differentiation of the major mycoplasma contaminants in cell cultures using real-time PCR with SYBR Green I and melting curve analysis. Microbiology and Immunology, 49(9), 859–863. https://doi.org/10.1111/j.1348-0421.2005.tb03675.x

21. He, J., Nguyen, A. T., & Zhang, Y. (2011). KDM2B/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia. Blood, 117(14), 3869–3880. https://doi.org/10.1182/blood-2010-10-312736

22. Heidelberger, C., Chaudhuri, N. K., Danneberg, P., Mooren, D., Griesbach, L., Duschinsky, R., Schnitzer, R. J., Pleven, E., & Scheiner, J. (1957). Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature, 179(4561), 663– 666. https://doi.org/10.1038/179663a0

23. Heinemann, B., Nielsen, J. M., Hudlebusch, H. R., Lees, M. J., Larsen, D. V., Boesen, T., Labelle, M., Gerlach, L.-O., Birk, P., & Helin, K. (2014). Inhibition of demethylases by GSK-J1/J4. Nature, 514(7520), E1–E2. https://doi.org/10.1038/nature13688

24. Hong, X., Xu, Y., Qiu, X., Zhu, Y., Feng, X., Ding, Z., Zhang, S., Zhong, L., Zhuang, Y., Su, C., Hong, X., & Cai, J. (2016). MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B. Oncotarget, 7(16), 22092–22102. https://doi.org/10.18632/oncotarget.8020

25. Huang, L., Snyder, A. R., & Morgan, W. F. (2003). Radiation-induced genomic instability and its implications for radiation carcinogenesis. Oncogene, 22(37), 5848–5854. https://doi.org/10.1038/sj.onc.1206697

26. Johannes, C. M., Henry, C. J., Turnquist, S. E., Hamilton, T. A., Smith, A. N., Chun, R., & Tyler, J. W. (2007). Hemangiosarcoma in cats: 53 cases (1992-2002). Journal of the American Veterinary Medical Association, 231(12), 1851–1856. https://doi.org/10.2460/javma.231.12.1851

27. Kim, J. J., & Tannock, I. F. (2005). Repopulation of cancer cells during therapy: An important cause of treatment failure. Nature Reviews. Cancer, 5(7), 516–525. https://doi.org/10.1038/nrc1650

28. Kim, J.-H., Graef, A. J., Dickerson, E. B., & Modiano, J. F. (2015). Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives. Veterinary Sciences, 2(4), 388–405. https://doi.org/10.3390/vetsci2040388

29. Kottakis, F., Foltopoulou, P., Sanidas, I., Keller, P., Wronski, A., Dake, B. T., Ezell, S. A., Shen, Z., Naber, S. P., Hinds, P. W., McNiel, E., Kuperwasser, C., & Tsichlis, P. N. (2014). NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells. Cancer Research, 74(14), 3935–3946. https://doi.org/10.1158/0008-5472.CAN-13-2733

30. Kottakis, F., Polytarchou, C., Foltopoulou, P., Sanidas, I., Kampranis, S. C., & Tsichlis, P. N. (2011). FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Molecular Cell, 43(2), 285–298. https://doi.org/10.1016/j.molcel.2011.06.020

31. Kurt, I. C., Sur, I., Kaya, E., Cingoz, A., Kazancioglu, S., Kahya, Z., Toparlak, O. D., Senbabaoglu, F., Kaya, Z., Ozyerli, E., Karahüseyinoglu, S., Lack, N. A., Gümüs, Z. H., Onder, T. T., & Bagci-Onder, T. (2017). KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL. Cell Death & Disease, 8(6), e2897. https://doi.org/10.1038/cddis.2017.288

32. Li, B., & Dewey, C. N. (2011). RSEM: Accurate transcript quantification from RNA- Seq data with or without a reference genome. BMC Bioinformatics, 12(1), 323. https://doi.org/10.1186/1471-2105-12-323

33. Li, Y., Zhang, M., Sheng, M., Zhang, P., Chen, Z., Xing, W., Bai, J., Cheng, T., Yang, F.-C., & Zhou, Y. (2018). Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology, 144(6), 1065–1077. https://doi.org/10.1007/s00432-018-2631-7

34. Maharani, A., Aoshima, K., Onishi, S., Gulay, K. C. M., Kobayashi, A., & Kimura, T. (2018). Cellular atypia is negatively correlated with immunohistochemical reactivity of CD31 and vWF expression levels in canine hemangiosarcoma. Journal of Veterinary Medical Science, 80(2), 213–218. https://doi.org/10.1292/jvms.17-0561

35. Mboko, W. P., Mounce, B. C., Wood, B. M., Kulinski, J. M., Corbett, J. A., & Tarakanova, V. L. (2012). Coordinate Regulation of DNA Damage and Type I Interferon Responses Imposes an Antiviral State That Attenuates Mouse Gammaherpesvirus Type 68 Replication in Primary Macrophages. Journal of Virology, 86(12), 6899–6912. https://doi.org/10.1128/JVI.07119-11

36. Meerbrey, K. L., Hu, G., Kessler, J. D., Roarty, K., Li, M. Z., Fang, J. E., Herschkowitz, J. I., Burrows, A. E., Ciccia, A., Sun, T., Schmitt, E. M., Bernardi, R. J., Fu, X., Bland, C. S., Cooper, T. A., Schiff, R., Rosen, J. M., Westbrook, T. F., & Elledge, S. J. (2011). The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America, 108(9), 3665–3670. https://doi.org/10.1073/pnas.1019736108

37. Megquier, K., Turner-Maier, J., Swofford, R., Kim, J.-H., Sarver, A. L., Wang, C., Sakthikumar, S., Johnson, J., Koltookian, M., Lewellen, M., Scott, M. C., Schulte, A. J., Borst, L., Tonomura, N., Alfoldi, J., Painter, C., Thomas, R., Karlsson, E. K., Breen, M., … Lindblad-Toh, K. (2019). Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma. Molecular Cancer Research, 17(12), 2410–2421. https://doi.org/10.1158/1541- 7786.MCR-19-0221

38. Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., Carpenter, A. E., Foo, S. Y., Stewart, S. A., Stockwell, B. R., Hacohen, N., Hahn, W. C., Lander, E. S., Sabatini, D. M., & Root, D. E. (2006). A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen. Cell, 124(6), 1283–1298. https://doi.org/10.1016/j.cell.2006.01.040

39. Moosavi, A., & Motevalizadeh Ardekani, A. (2016). Role of Epigenetics in Biology and Human Diseases. Iranian Biomedical Journal, 20(5), 246–258. https://doi.org/10.22045/ibj.2016.01

40. Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., Houstis, N., Daly, M. J., Patterson, N., Mesirov, J. P., Golub, T. R., Tamayo, P., Spiegelman, B., Lander, E. S., Hirschhorn, J. N., … Groop, L. C. (2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics, 34(3), 267–273. https://doi.org/10.1038/ng1180

41. Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., Jackman, S., Krzywinski, M., Scott, D. W., Trinh, D. L., Tamura-Wells, J., Li, S., Firme, M. R., Rogic, S., Griffith, M., … Marra, M. A. (2011). Frequent mutation of histone-modifying genes in non- Hodgkin lymphoma. Nature, 476(7360), 298–303. https://doi.org/10.1038/nature10351

42. Morita, A., Aoshima, K., Gulay, K. C. M., Onishi, S., Shibata, Y., Yasui, H., Kobayashi, A., & Kimura, T. (2019). High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines. Research in Veterinary Science, 127, 1–10. https://doi.org/10.1016/j.rvsc.2019.09.011

43. Murai, A., Asa, S. A., Kodama, A., Hirata, A., Yanai, T., & Sakai, H. (2012). Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines. BMC Veterinary Research, 8(1), 128. https://doi.org/10.1186/1746-6148-8-128

44. Odom, A. L., Hatwig, C. A., Stanley, J. S., & Benson, A. M. (1992). Biochemical determinants of adriamycin® toxicity in mouse liver, heart and intestine. Biochemical Pharmacology, 43(4), 831–836. https://doi.org/10.1016/0006- 2952(92)90250-M

45. Peta, E., Sinigaglia, A., Masi, G., Di Camillo, B., Grassi, A., Trevisan, M., Messa, L., Loregian, A., Manfrin, E., Brunelli, M., Martignoni, G., Palù, G., & Barzon, L. (2018). HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys. Oncogene, 37(12), 1654–1668. https://doi.org/10.1038/s41388-017-0083-1

46. Peters, I. R., Peeters, D., Helps, C. R., & Day, M. J. (2007). Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies. Veterinary Immunology and Immunopathology, 117(1–2), 55–66. https://doi.org/10.1016/j.vetimm.2007.01.011

47. Prymak, C., McKee, L. J., Goldschmidt, M. H., & Glickman, L. T. (1988). Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). Journal of the American Veterinary Medical Association, 193(6), 706–712.

48. Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010). edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26(1), 139–140. https://doi.org/10.1093/bioinformatics/btp616

49. Sastry, G. A. (1951). Angiosarcoma (hemangioendothelioma) in the thorax of a mule. The Veterinary Record, 63(8), 145–147. https://doi.org/10.1136/vr.63.8.145

50. Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012). NIH Image to ImageJ: 25 years of image analysis. Nature Methods, 9(7), 671–675. https://doi.org/10.1038/nmeth.2089

51. Sharma, S., Kelly, T. K., & Jones, P. A. (2010). Epigenetics in cancer. Carcinogenesis, 31(1), 27–36. https://doi.org/10.1093/carcin/bgp220

52. Sheltzer, J. M., Blank, H. M., Pfau, S. J., Tange, Y., George, B. M., Humpton, T. J., Brito, I. L., Hiraoka, Y., Niwa, O., & Amon, A. (2011). Aneuploidy Drives Genomic Instability in Yeast. Science, 333(6045), 1026–1030. https://doi.org/10.1126/science.1206412

53. Shimizu, H., Nagel, D., & Toth, B. (1974). Ethylhydrazine hydrochloride as a tumor inducer in mice. International Journal of Cancer, 13(4), 500–505. https://doi.org/10.1002/ijc.2910130409

54. Stokes, M. P., Rush, J., Macneill, J., Ren, J. M., Sprott, K., Nardone, J., Yang, V., Beausoleil, S. A., Gygi, S. P., Livingstone, M., Zhang, H., Polakiewicz, R. D., & Comb, M. J. (2007). Profiling of UV-induced ATM/ATR signaling pathways. Proceedings of the National Academy of Sciences of the United States of America, 104(50), 19855–19860. https://doi.org/10.1073/pnas.0707579104

55. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550. https://doi.org/10.1073/pnas.0506580102

56. Thomas, R., Borst, L., Rotroff, D., Motsinger-Reif, A., Lindblad-Toh, K., Modiano, J. F., & Breen, M. (2014). Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma. Chromosome Research : An International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology, 22(3), 305–319. https://doi.org/10.1007/s10577-014-9406-z

57. Tzatsos, A., Pfau, R., Kampranis, S. C., & Tsichlis, P. N. (2009). Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus. Proceedings of the National Academy of Sciences, 106(8), 2641–2646. https://doi.org/10.1073/pnas.0813139106

58. van Haaften, G., Dalgliesh, G. L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O’Meara, S., Teague, J., Butler, A., Hinton, J., Latimer, C., Andrews, J., Barthorpe, S., Beare, D., Buck, G., Campbell, P. J., Cole, J., … Futreal, P. A. (2009). Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nature Genetics, 41(5), 521–523. https://doi.org/10.1038/ng.349

59. Wang, T., Chen, K., Zeng, X., Yang, J., Wu, Y., Shi, X., Qin, B., Zeng, L., Esteban, M. A., Pan, G., & Pei, D. (2011). The Histone Demethylases Jhdm1a/1b Enhance Somatic Cell Reprogramming in a Vitamin-C-Dependent Manner. Cell Stem Cell, 9(6), 575–587. https://doi.org/10.1016/j.stem.2011.10.005

60. Wild-Bode, C., Weller, M., Rimner, A., Dichgans, J., & Wick, W. (2001). Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma. Cancer Research, 61(6), 2744–2750.

61. YAMAMOTO, S., HOSHI, K., HIRAKAWA, A., CHIMURA, S., KOBAYASHI, M., & MACHIDA, N. (2013). Epidemiological, Clinical and Pathological Features of Primary Cardiac Hemangiosarcoma in Dogs: A Review of 51 Cases. The Journal of Veterinary Medical Science, 75(11), 1433–1441. https://doi.org/10.1292/jvms.13-0064

62. Yan, M., Yang, X., Wang, H., & Shao, Q. (2018a). The critical role of histone lysine demethylase KDM2B in cancer. American Journal of Translational Research, 10(8), 2222–2233.

63. Yan, M., Yang, X., Wang, H., & Shao, Q. (2018b). The critical role of histone lysine demethylase KDM2B in cancer. American Journal of Translational Research, 10(8), 2222–2233.

64. Yoshino, H., Ueda, T., Kawahata, M., Kobayashi, K., Ebihara, Y., Manabe, A., Tanaka, R., Ito, M., Asano, S., Nakahata, T., & Tsuji, K. (2000). Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi- scid mice. Bone Marrow Transplantation, 26(11), 1211–1216. https://doi.org/10.1038/sj.bmt.1702702

65. Young, R. J., Brown, N. J., Reed, M. W., Hughes, D., & Woll, P. J. (2010). Angiosarcoma. The Lancet. Oncology, 11(10), 983–991. https://doi.org/10.1016/S1470-2045(10)70023-1

66. Zhu, J., Tsai, H.-J., Gordon, M. R., & Li, R. (2018). Cellular Stress Associated with Aneuploidy. Developmental Cell, 44(4), 420–431. https://doi.org/10.1016/j.devcel.2018.02.002